University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
Do answers to the mysteries of cancer lie hidden within the DNA of tumor cells? Researchers think so.
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Novartis is one of this year’s top 20 employers in an annual survey from Science.
Emerging markets in Africa are gearing up for clinical research. Learn how Novartis is working with Ghana and Kenya to build research capacity.
Ad hoc announcement pursuant to article 53 Listing Rules.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.